1. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma
   Wan Sun et al, 2021, Frontiers in Oncology CrossRef
2. Reprogramming of glycolysis by chemical carcinogens during tumor development
   Leonard Clinton D’Souza et al, 2022, Seminars in Cancer Biology CrossRef
3. ANGPTL4 overexpression is associated with progression and poor prognosis in breast cancer
   Jing Zhao et al, 2020, Oncology Letters CrossRef
4. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
   Anna Cinkajzlová et al, 2018, Nutrition & Diabetes CrossRef
5. Treatment resistance to melanoma therapeutics on a single cell level
   Lijun Yao et al, 2024, Scientific Reports CrossRef
6. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
   Zhaoyong Li et al, 2016, Cellular and Molecular Life Sciences CrossRef
7. Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma
   Y-H Liao et al, 2017, Oncogene CrossRef
8. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
   Tae Hyun Kim et al, 2021, Biomedicines CrossRef
9. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
   Meenakshi Vachher et al, 2022, Journal of Cellular Biochemistry CrossRef
10. Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells
    István Szász et al, 2019, Melanoma Research CrossRef
11. Hepatokines and metabolism: Deciphering communication from the liver
    Sharon O. Jensen-Cody et al, 2021, Molecular Metabolism CrossRef
12. Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis
    Preety Bajwa et al, 2023, JCI Insight CrossRef